Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > New Dr Salzman Interview
View:
Post by PTBailey on Aug 12, 2021 8:41pm

New Dr Salzman Interview

Hey everyone new interview by Drew with Dr. Salzman. Read to the end for his reference to phase 3.
https://claritasinvestors.com/index.php?%2Ftopic%2F1035-salzman-interview-11-august-2021-phase-2 covid%2F&fbclid=IwAR3PwynHlu0l8yH8I66MZbMjJZLGPy0wwQ9AqEYylxUaGC87H9aWbu4sSAc
Comment by Amazigh on Aug 13, 2021 5:43am
AWESOME INTERVIEW! Especially the end. We're going to be R-I-C-H, rich!!!
Comment by Chritters on Aug 13, 2021 9:54am
No one can see these interveiws as you have blocked and removed everyone from your site! Maybe copy and paste them on here and CEO!
Comment by Amazigh on Aug 13, 2021 10:20am
Hey Chritters, the claritasinvestors site is not mine, so I cannot copy and paste it on other fora. You can ask Drew or Paul.
Claritas Pharmaceuticals Inc